Juvenile Diabetes Research Foundation (JDRF): Therapeutic Development and Early Clinical Testing of T Cell Targeted Immunotherapies for the Treatment of Type 1 Diabetes

Aim: to facilitate faster translation of important type 1 diabetes (T1D) related research findings into viable immune therapeutic candidates for human testing. This RFA intends to specifically support late stage preclinical development of promising candidate immune drug and biologic therapies.

Funding: vary depending on the scope and overall objectives of a project.

http://grantcenter.jdrf.org/rfa/therapeutic-development-and-early-clinical-testing-of-t-cell-targeted-immunotherapies-for-the-treatment-of-type-1-diabetes/